How I treat hypereosinophilic syndromes
- 29 October 2009
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 114 (18), 3736-3741
- https://doi.org/10.1182/blood-2009-07-143552
Abstract
Hypereosinophilic syndromes (HESs) are a heterogeneous group of uncommon disorders characterized by marked peripheral eosinophilia and end organ manifestations attributable to the eosinophilia or unexplained in the clinical setting. Whereas corticosteroids remain the mainstay of treatment for most patients, recent diagnostic advances and the development of novel targeted therapies, including tyrosine kinase inhibitors and humanized monoclonal antibodies, have increased the complexity of therapeutic decisions in HESs. This review presents a treatment-based approach to the diagnosis and classification of patients with peripheral blood eosinophilia of 1.5 x 10(9)/L (1500/mm3) or higher and discusses the role of currently available therapeutic agents in the treatment of these patients.This publication has 40 references indexed in Scilit:
- Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyJournal of Allergy and Clinical Immunology, 2009
- Phase II study of imatinib mesylate as therapy for patients with systemic mastocytosisLeukemia Research, 2009
- Synchronous FIP1L1–PDGFRA‐positive chronic eosinophilic leukemia and T‐cell lymphoblastic lymphoma: a bilineal clonal malignancyEuropean Journal of Haematology, 2007
- Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosingBlood, 2007
- Sorafenib is a potent inhibitor of FIP1L1-PDGFRα and the imatinib-resistant FIP1L1-PDGFRα T674I mutantBlood, 2006
- Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcriptBone Marrow Transplantation, 2006
- Familial eosinophilia: a benign disorder?Blood, 2004
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaThe New England Journal of Medicine, 1999
- Endomyocardial disease and eosinophilia. Report of a case.Circulation, 1978
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975